Guru Ownership Trend
Guru Analysis for Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc. (TERN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $61.77 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $18.36 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 31.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Terns Pharmaceuticals, Inc. (TERN)
Major holders include Steven Cohen ($23.18 M), Renaissance Technologies (RenTech) ($18.86 M), Paul Tudor Jones ($2.96 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.17 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $18.36 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited TERN. The total reported sell value was $8.48 M.
Yes, 3 managers opened new positions in TERN, and 1 increased their existing holdings. The total reported buy value was $26.85 M.